Iron chelating therapy in thalassemia: current problems.
Russo
G
G
Clinica Pediatrica, Università di Catania.
D000293:Adolescent; D015913:Chelation Therapy; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006130:Growth Disorders / Q000209:etiology; D006333:Heart Failure / Q000209:etiology; D006486:Hemosiderosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007501:Iron; D008297:Male; D010349:Patient Compliance; D011628:Puberty, Delayed / Q000209:etiology; D013789:Thalassemia / Q000150:complications* / Q000628:therapy; D065227:Transfusion Reaction
D007501:Iron; D003676:Deferoxamine